| |
| |
|
| Insider
Information: |
Vanlent Anne |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
71,063 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$197,136 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
71,063 |
|
|
| Total
Value |
$197,136 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
Director |
2010-09-20 |
0 |
2004-10-01 |
0 |
Premium* |
|
|
Integra Lifesciences Holdings Corp |
IART |
Director |
2011-05-17 |
5,978 |
2005-06-08 |
0 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
Director |
2016-11-29 |
0 |
2014-05-08 |
0 |
Premium* |
|
|
Vaxart Inc |
VXRT |
Director |
2015-06-22 |
35,000 |
2015-06-22 |
0 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
Director |
2016-11-29 |
4,102 |
2016-11-29 |
0 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
Director |
2017-12-11 |
0 |
2017-06-20 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
Director |
2019-05-09 |
25,983 |
2019-05-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TRVI |
Trevi Therapeutics, Inc. |
Director |
– • – |
2019-05-09 |
4 |
B |
$10.00 |
$50,000 |
D/D |
5,000 |
25,983 |
2.39 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Director |
– • – |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
20,983 |
20,983 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Director |
– • – |
2017-12-11 |
4 |
D |
$1.52 |
$19,000 |
D/D |
(12,500) |
0 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Director |
– • – |
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2016-11-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,000) |
0 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2016-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,102 |
4,102 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
• • – |
2015-06-22 |
4 |
B |
$2.20 |
$76,892 |
D/D |
35,000 |
35,000 |
2.39 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2014-05-08 |
4 |
B |
$33.20 |
$135,110 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
| IART |
Integra Lifesciences Hold... |
Director |
– • – |
2011-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
5,978 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Director |
– • – |
2011-01-13 |
4 |
AS |
$47.49 |
$250,277 |
D/D |
(5,270) |
3,478 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Director |
– • – |
2011-01-13 |
4 |
OE |
$33.32 |
$249,900 |
D/D |
7,500 |
8,748 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2010-09-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,491) |
0 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2010-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
50,412 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2008-11-06 |
4 |
S |
$1.01 |
$6,969 |
D/D |
(6,900) |
44,412 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2008-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
51,312 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2007-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
45,312 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2006-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
90 |
33,312 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2006-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
273 |
33,222 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2006-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
89 |
32,949 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
208 |
32,860 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2006-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
81 |
32,652 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2006-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
74 |
32,571 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2006-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
208 |
32,497 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2006-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
66 |
32,289 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
officerTitle |
– • – |
2005-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
79 |
26,070 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
